Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 16, 2022 Filed May 19, 2022 00:08 UTC |
Kaufman FrancineDirector · Chief Medical Officer
|
Tax withholdingCommon Stock | 54,538 | $1.13 | $61,627.94 |
DisclosureSEC source: 0001209191-22-030282 · doc4.xml · nonDerivative · entry 1 Kaufman Francine · CIK 0001769791 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,167,637 F1 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:39 UTC |
Larkin SharonDirector
|
GrantCommon Stock | 3,745 | $1.94 | $7,265.30 |
DisclosureSEC source: 0001209191-22-023334 · doc4.xml · nonDerivative · entry 1 Larkin Sharon · CIK 0001898172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,860 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $7,265.30 divided by $1.94, the closing price of Issuer's common stock on the NYSE American on April 1, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:34 UTC |
DeFalco Stephen PDirector
|
GrantCommon Stock | 12,886 | $1.94 | $24,998.84 |
DisclosureSEC source: 0001209191-22-023326 · doc4.xml · nonDerivative · entry 1 DeFalco Stephen P · CIK 0001666964 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,206,217 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $24,998.84 divided by $1.94, the closing price of Issuer's common stock on the NYSE American on April 1, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:36 UTC |
Fiorentino EdwardDirector
|
GrantCommon Stock | 7,280 | $1.94 | $14,123.20 |
DisclosureSEC source: 0001209191-22-023329 · doc4.xml · nonDerivative · entry 1 Fiorentino Edward · CIK 0001666972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,019 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $14,123.20 divided by $1.94, the closing price of Issuer's common stock on the NYSE American on April 1, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:37 UTC |
Prince Douglas SDirector
|
GrantCommon Stock | 4,832 | $1.94 | $9,374.08 |
DisclosureSEC source: 0001209191-22-023331 · doc4.xml · nonDerivative · entry 1 Prince Douglas S · CIK 0001666995 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,914 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $9,374.08 divided by $1.94, the closing price of Issuer's common stock on the NYSE American on April 1, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:36 UTC |
Steven EdelmanDirector
|
GrantCommon Stock | 4,977 | $1.94 | $9,655.38 |
DisclosureSEC source: 0001209191-22-023330 · doc4.xml · nonDerivative · entry 1 Steven Edelman · CIK 0001683354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 394,571 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $9,655.38 divided by $1.94, the closing price of Issuer's common stock on the NYSE American on April 1, 2022. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 23:26 UTC |
Fiorentino EdwardDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 83,900 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001209191-22-018985 · doc4.xml · derivative · entry 3 Fiorentino Edward · CIK 0001666972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 83,900 shares Expires 2022-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the exercise of a stock option held by the Reporting Person that was scheduled to expire, if not exercised, on March 14, 2022. F4 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 23:26 UTC |
Fiorentino EdwardDirector
|
SaleCommon Stock | 63,553 | $1.65 | $104,862.45 |
DisclosureSEC source: 0001209191-22-018985 · doc4.xml · nonDerivative · entry 2 Fiorentino Edward · CIK 0001666972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,739 F2 · kind: Represents the required number of shares sold to satisfy the exercise price of the expiring option and the Reporting Person's tax obligations resulting from the exercise. Beyond this required number of shares, no additional shares were sold by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.65 to $1.67 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 23:26 UTC |
Fiorentino EdwardDirector
|
Exercise / conversionCommon Stock | 83,900 | $0.54 | $45,306.00 |
DisclosureSEC source: 0001209191-22-018985 · doc4.xml · nonDerivative · entry 1 Fiorentino Edward · CIK 0001666972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 491,292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the exercise of a stock option held by the Reporting Person that was scheduled to expire, if not exercised, on March 14, 2022. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 00:44 UTC |
Goodnow Timothy TDirector · President and CEO
|
SaleCommon Stock | 464,390 | $2.46 | $1,142,399.40 |
DisclosureSEC source: 0001209191-22-009554 · doc4.xml · nonDerivative · entry 2 Goodnow Timothy T · CIK 0001667588 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,737,786 F2 · kind: Represents shares sold to cover tax obligations upon the vesting of RSUs. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.575 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 19:48 UTC |
Panlilio MirasolVP Global Sales and Marketing
|
SaleCommon Stock | 105,760 | $2.46 | $260,169.60 |
DisclosureSEC source: 0001209191-22-009558 · doc4.xml · nonDerivative · entry 2 Panlilio Mirasol · CIK 0001667551 · VP Global Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,083,788 F2 · kind: Represents shares sold to cover tax obligations upon the vesting of RSUs. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.575 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 00:46 UTC |
JAIN MukulChief Operating Officer
|
SaleCommon Stock | 150,197 | $2.46 | $369,484.62 |
DisclosureSEC source: 0001209191-22-009556 · doc4.xml · nonDerivative · entry 2 JAIN Mukul · CIK 0001667593 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,849,410 F2 · kind: Represents shares sold to cover tax obligations upon the vesting of RSUs. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.575 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 00:45 UTC |
Horton Kenneth LGC & Corp. Development Advisor
|
SaleCommon Stock | 143,126 | $2.46 | $352,089.96 |
DisclosureSEC source: 0001209191-22-009555 · doc4.xml · nonDerivative · entry 2 Horton Kenneth L · CIK 0001552047 · GC & Corp. Development Advisor 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,217,425 F2 · kind: Represents shares sold to cover tax obligations upon the vesting of RSUs. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.575 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 00:49 UTC |
Tressler Nick B.Chief Financial Officer
|
SaleCommon Stock | 72,873 | $2.46 | $179,267.58 |
DisclosureSEC source: 0001209191-22-009559 · doc4.xml · nonDerivative · entry 2 Tressler Nick B. · CIK 0001794362 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,410 F2 · kind: Represents shares sold to cover tax obligations upon the vesting of RSUs. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.575 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 00:47 UTC |
Kaufman FrancineDirector · Chief Medical Officer
|
SaleCommon Stock | 163,870 | $2.46 | $403,120.20 |
DisclosureSEC source: 0001209191-22-009557 · doc4.xml · nonDerivative · entry 2 Kaufman Francine · CIK 0001769791 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,222,175 F2 · kind: Represents shares sold to cover tax obligations upon the vesting of RSUs. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.575 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 00:44 UTC |
Goodnow Timothy TDirector · President and CEO
|
GrantCommon Stock | 673,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009554 · doc4.xml · nonDerivative · entry 1 Goodnow Timothy T · CIK 0001667588 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,202,176 F1 · shares: Represents a performance-based restricted stock unit ("RSU") award, which represent a contingent right to receive one share of the Issuer's common stock and vest upon the achievement of certain performance targets, subject to the Reporting Person's continuous service through the vesting events. 100% of the RSUs vested on February 10, 2022 upon the achievement of the performance vesting criteria. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 19:48 UTC |
Panlilio MirasolVP Global Sales and Marketing
|
GrantCommon Stock | 210,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009558 · doc4.xml · nonDerivative · entry 1 Panlilio Mirasol · CIK 0001667551 · VP Global Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,189,548 F1 · shares: Represents a performance-based restricted stock unit ("RSU") award, which represent a contingent right to receive one share of the Issuer's common stock and vest upon the achievement of certain performance targets, subject to the Reporting Person's continuous service through the vesting events. 100% of the RSUs vested on February 10, 2022 upon the achievement of the performance vesting criteria. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 00:46 UTC |
JAIN MukulChief Operating Officer
|
GrantCommon Stock | 260,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009556 · doc4.xml · nonDerivative · entry 1 JAIN Mukul · CIK 0001667593 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,999,607 F1 · shares: Represents a performance-based restricted stock unit ("RSU") award, which represent a contingent right to receive one share of the Issuer's common stock and vest upon the achievement of certain performance targets, subject to the Reporting Person's continuous service through the vesting events. 100% of the RSUs vested on February 10, 2022 upon the achievement of the performance vesting criteria. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 00:45 UTC |
Horton Kenneth LGC & Corp. Development Advisor
|
GrantCommon Stock | 255,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009555 · doc4.xml · nonDerivative · entry 1 Horton Kenneth L · CIK 0001552047 · GC & Corp. Development Advisor 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,360,551 F1 · shares: Represents a performance-based restricted stock unit ("RSU") award, which represent a contingent right to receive one share of the Issuer's common stock and vest upon the achievement of certain performance targets, subject to the Reporting Person's continuous service through the vesting events. 100% of the RSUs vested on February 10, 2022 upon the achievement of the performance vesting criteria. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 00:49 UTC |
Tressler Nick B.Chief Financial Officer
|
GrantCommon Stock | 165,854 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009559 · doc4.xml · nonDerivative · entry 1 Tressler Nick B. · CIK 0001794362 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,283 F1 · shares: Represents a performance-based restricted stock unit ("RSU") award, which represent a contingent right to receive one share of the Issuer's common stock and vest upon the achievement of certain performance targets, subject to the Reporting Person's continuous service through the vesting events. 100% of the RSUs vested on February 10, 2022 upon the achievement of the performance vesting criteria. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 00:47 UTC |
Kaufman FrancineDirector · Chief Medical Officer
|
GrantCommon Stock | 310,884 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009557 · doc4.xml · nonDerivative · entry 1 Kaufman Francine · CIK 0001769791 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,386,045 F1 · shares: Represents a performance-based restricted stock unit ("RSU") award, which represent a contingent right to receive one share of the Issuer's common stock and vest upon the achievement of certain performance targets, subject to the Reporting Person's continuous service through the vesting events. 100% of the RSUs vested on February 10, 2022 upon the achievement of the performance vesting criteria. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 23:16 UTC |
Fiorentino EdwardDirector
|
GrantCommon Stock | 5,136 | $2.75 | $14,124.00 |
DisclosureSEC source: 0001209191-22-001944 · doc4.xml · nonDerivative · entry 1 Fiorentino Edward · CIK 0001666972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 407,392 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $14,124.00 divided by $2.75, the closing price of Issuer's common stock on the NYSE American on January 3, 2022. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 23:14 UTC |
DeFalco Stephen PDirector
|
GrantCommon Stock | 9,090 | $2.75 | $24,997.50 |
DisclosureSEC source: 0001209191-22-001940 · doc4.xml · nonDerivative · entry 1 DeFalco Stephen P · CIK 0001666964 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,193,331 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $24,997.50 divided by $2.75, the closing price of Issuer's common stock on the NYSE American on January 3, 2022. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 23:17 UTC |
Prince Douglas SDirector
|
GrantCommon Stock | 3,409 | $2.75 | $9,374.75 |
DisclosureSEC source: 0001209191-22-001946 · doc4.xml · nonDerivative · entry 1 Prince Douglas S · CIK 0001666995 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,082 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $9,374.75 divided by $2.75, the closing price of Issuer's common stock on the NYSE American on January 3, 2022. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 23:15 UTC |
Steven EdelmanDirector
|
GrantCommon Stock | 3,511 | $2.75 | $9,655.25 |
DisclosureSEC source: 0001209191-22-001942 · doc4.xml · nonDerivative · entry 1 Steven Edelman · CIK 0001683354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389,594 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $9,655.25 divided by $2.75, the closing price of Issuer's common stock on the NYSE American on January 3, 2022. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:37 UTC |
Larkin SharonDirector
|
GrantCommon Stock | 72,115 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-069065 · doc4.xml · nonDerivative · entry 1 Larkin Sharon · CIK 0001898172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,115 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in three equal annual installments commencing on December 8, 2022, subject to the Reporting Person's continuous service through each such vesting date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 06, 2021 Filed Dec 9, 2021 01:42 UTC |
Raab Anthony R.Director
|
SaleCommon Stock | 136,538 | $2.53 | $345,441.14 |
DisclosureSEC source: 0001209191-21-068630 · doc4.xml · nonDerivative · entry 2 Raab Anthony R. · CIK 0001827192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,022 F3 · kind: Represents shares sold by the Reporting Person to satisfy the Reporting Person's tax obligations resulting from the settlement of restricted stock units ("RSUs") that vested on October 1, 2021. The sales were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 16, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.62 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 14:22 UTC |
JAIN MukulChief Operating Officer
|
SaleCommon Stock | 100,000 | $3.70 | $370,000.00 |
DisclosureSEC source: 0001209191-21-065378 · doc4.xml · nonDerivative · entry 2 JAIN Mukul · CIK 0001667593 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,739,124 F3 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.68 to $3.775 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 14:23 UTC |
Kaufman FrancineDirector · Chief Medical Officer
|
SaleCommon Stock | 20,998 | $3.70 | $77,692.60 |
DisclosureSEC source: 0001209191-21-065379 · doc4.xml · nonDerivative · entry 2 Kaufman Francine · CIK 0001769791 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,075,161 F2 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.69 to $3.73 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 15, 2021 Filed Nov 18, 2021 09:25 UTC |
Panlilio MirasolVP Global Sales and Marketing
|
Tax withholdingCommon Stock | 47,851 | $3.80 | $181,833.80 |
DisclosureSEC source: 0001209191-21-065381 · doc4.xml · nonDerivative · entry 1 Panlilio Mirasol · CIK 0001667551 · VP Global Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 979,528 F1 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units. Read SEC document |
| November 15, 2021 Filed Nov 18, 2021 14:29 UTC |
Goodnow Timothy TDirector · President and CEO
|
Tax withholdingCommon Stock | 297,995 | $3.80 | $1,132,381.00 |
DisclosureSEC source: 0001209191-21-065383 · doc4.xml · nonDerivative · entry 1 Goodnow Timothy T · CIK 0001667588 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,528,908 F1 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units. Read SEC document |
| November 15, 2021 Filed Nov 18, 2021 14:22 UTC |
JAIN MukulChief Operating Officer
|
Tax withholdingCommon Stock | 115,138 | $3.80 | $437,524.40 |
DisclosureSEC source: 0001209191-21-065378 · doc4.xml · nonDerivative · entry 1 JAIN Mukul · CIK 0001667593 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,839,124 F1 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units. F2 · balance_after: Includes 3,917 shares acquired under the Issuer's employee stock purchase plan on July 31, 2021. Read SEC document |
| November 15, 2021 Filed Nov 18, 2021 14:26 UTC |
Horton Kenneth LGC & Corp. Development Advisor
|
Tax withholdingCommon Stock | 46,426 | $3.80 | $176,418.80 |
DisclosureSEC source: 0001209191-21-065382 · doc4.xml · nonDerivative · entry 1 Horton Kenneth L · CIK 0001552047 · GC & Corp. Development Advisor 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,105,264 F1 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units. Read SEC document |
| November 15, 2021 Filed Nov 18, 2021 14:24 UTC |
Tressler Nick B.Chief Financial Officer
|
Tax withholdingCommon Stock | 7,850 | $3.80 | $29,830.00 |
DisclosureSEC source: 0001209191-21-065380 · doc4.xml · nonDerivative · entry 1 Tressler Nick B. · CIK 0001794362 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,429 F1 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units. F2 · balance_after: Includes 4,512 shares acquired under the Issuer's employee stock purchase plan on July 31, 2021. Read SEC document |
| November 15, 2021 Filed Nov 18, 2021 14:23 UTC |
Kaufman FrancineDirector · Chief Medical Officer
|
Tax withholdingCommon Stock | 55,531 | $3.80 | $211,017.80 |
DisclosureSEC source: 0001209191-21-065379 · doc4.xml · nonDerivative · entry 1 Kaufman Francine · CIK 0001769791 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,096,159 F1 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 21:47 UTC |
Fiorentino EdwardDirector
|
GrantCommon Stock | 4,094 | $3.45 | $14,124.30 |
DisclosureSEC source: 0001209191-21-059633 · doc4.xml · nonDerivative · entry 1 Fiorentino Edward · CIK 0001666972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 402,256 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $14,124.30 divided by $3.45, the closing price of Issuer's common stock on the NYSE American on October 1, 2021. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 21:49 UTC |
DeFalco Stephen PDirector
|
GrantCommon Stock | 7,246 | $3.45 | $24,998.70 |
DisclosureSEC source: 0001209191-21-059635 · doc4.xml · nonDerivative · entry 1 DeFalco Stephen P · CIK 0001666964 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,184,241 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $24,998.70 divided by $3.45, the closing price of Issuer's common stock on the NYSE American on October 1, 2021. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 21:46 UTC |
Prince Douglas SDirector
|
GrantCommon Stock | 2,717 | $3.45 | $9,373.65 |
DisclosureSEC source: 0001209191-21-059631 · doc4.xml · nonDerivative · entry 1 Prince Douglas S · CIK 0001666995 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,673 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $9,373.65 divided by $3.45, the closing price of Issuer's common stock on the NYSE American on October 1, 2021. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 21:47 UTC |
Steven EdelmanDirector
|
GrantCommon Stock | 2,798 | $3.45 | $9,653.10 |
DisclosureSEC source: 0001209191-21-059634 · doc4.xml · nonDerivative · entry 1 Steven Edelman · CIK 0001683354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,083 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $9,653.10 divided by $3.45, the closing price of Issuer's common stock on the NYSE American on October 1, 2021. Read SEC document |
| August 25, 2021 Filed Aug 27, 2021 00:25 UTC |
ROEDER DOUGLAS ADirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 86,930 | $0.00 Strike: $1.97 | $0.00 |
DisclosureSEC source: 0001209191-21-053558 · doc4.xml · derivative · entry 6 ROEDER DOUGLAS A · CIK 0001270735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 86,930 shares Expires 2029-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested and exercisable. Read SEC document |
| August 25, 2021 Filed Aug 27, 2021 00:25 UTC |
ROEDER DOUGLAS ADirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 128,817 | $0.00 Strike: $1.35 | $0.00 |
DisclosureSEC source: 0001209191-21-053558 · doc4.xml · derivative · entry 5 ROEDER DOUGLAS A · CIK 0001270735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 128,817 shares Expires 2027-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested and exercisable. Read SEC document |
| August 25, 2021 Filed Aug 27, 2021 00:25 UTC |
ROEDER DOUGLAS ADirector
|
SaleCommon Stock | 215,747 | $3.50 | $755,114.50 |
DisclosureSEC source: 0001209191-21-053558 · doc4.xml · nonDerivative · entry 4 ROEDER DOUGLAS A · CIK 0001270735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,483 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.47 to $3.57 inclusive. Read SEC document |
| August 25, 2021 Filed Aug 27, 2021 00:25 UTC |
ROEDER DOUGLAS ADirector
|
Exercise / conversionCommon Stock | 86,930 | $1.97 | $171,252.10 |
DisclosureSEC source: 0001209191-21-053558 · doc4.xml · nonDerivative · entry 3 ROEDER DOUGLAS A · CIK 0001270735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2021 Filed Aug 27, 2021 00:25 UTC |
ROEDER DOUGLAS ADirector
|
Exercise / conversionCommon Stock | 128,817 | $1.35 | $173,902.95 |
DisclosureSEC source: 0001209191-21-053558 · doc4.xml · nonDerivative · entry 2 ROEDER DOUGLAS A · CIK 0001270735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2021 Filed Aug 27, 2021 00:25 UTC |
ROEDER DOUGLAS ADirector
|
SaleCommon Stock | 125,342 | $3.65 | $457,498.30 |
DisclosureSEC source: 0001209191-21-053558 · doc4.xml · nonDerivative · entry 1 ROEDER DOUGLAS A · CIK 0001270735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,483 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.64 to $3.675 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2). Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:52 UTC |
Fiorentino EdwardDirector
|
GrantCommon Stock | 4,035 | $3.50 | $14,122.50 |
DisclosureSEC source: 0001209191-21-045527 · doc4.xml · nonDerivative · entry 1 Fiorentino Edward · CIK 0001666972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,162 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $14,122.50 divided by $3.50, the closing price of Issuer's common stock on the NYSE American on July 1, 2021. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:59 UTC |
DeFalco Stephen PDirector
|
GrantCommon Stock | 7,142 | $3.50 | $24,997.00 |
DisclosureSEC source: 0001209191-21-045546 · doc4.xml · nonDerivative · entry 1 DeFalco Stephen P · CIK 0001666964 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,176,995 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $24,997.00 divided by $3.50, the closing price of Issuer's common stock on the NYSE American on July 1, 2021. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:53 UTC |
Prince Douglas SDirector
|
GrantCommon Stock | 2,678 | $3.50 | $9,373.00 |
DisclosureSEC source: 0001209191-21-045530 · doc4.xml · nonDerivative · entry 1 Prince Douglas S · CIK 0001666995 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,956 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $9,373.00 divided by $3.50, the closing price of Issuer's common stock on the NYSE American on July 1, 2021. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:50 UTC |
Steven EdelmanDirector
|
GrantCommon Stock | 2,758 | $3.50 | $9,653.00 |
DisclosureSEC source: 0001209191-21-045524 · doc4.xml · nonDerivative · entry 1 Steven Edelman · CIK 0001683354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,285 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $9,653.00 divided by $3.50, the closing price of Issuer's common stock on the NYSE American on July 1, 2021. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 18:17 UTC |
Panlilio MirasolVP Global Sales and Marketing
|
Tax withholdingCommon Stock | 8,602 | $3.69 | $31,741.38 |
DisclosureSEC source: 0001209191-21-041051 · doc4.xml · nonDerivative · entry 1 Panlilio Mirasol · CIK 0001667551 · VP Global Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,027,379 F1 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units. F2 · balance_after: Includes 12,000, 12,000 and 10,548 shares acquired under the Issuer's employee stock purchase plan on January 31, 2020, July 31, 2020 and January 29, 2021, respectively. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.